These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Memantine (Namenda) for moderate to severe Alzheimer's disease. Ables AZ Am Fam Physician; 2004 Mar; 69(6):1491-2. PubMed ID: 15053415 [No Abstract] [Full Text] [Related]
3. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date. Bullock R Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232 [TBL] [Abstract][Full Text] [Related]
6. Memantine: the next trend in academic performance enhancement? Ota KS; Godwin T J Am Osteopath Assoc; 2006 Jun; 106(6):358-9. PubMed ID: 16790543 [No Abstract] [Full Text] [Related]
8. [Mechanisms of action of Alzheimer medications]. Alhainen K Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001 [No Abstract] [Full Text] [Related]
9. Drugs for Alzheimer's disease. Cranwell-Bruce LA Medsurg Nurs; 2010; 19(1):51-3. PubMed ID: 20336985 [No Abstract] [Full Text] [Related]
10. Molecule of the month. Memantine hydrochloride. Drug News Perspect; 2003; 16(1):55. PubMed ID: 12682671 [No Abstract] [Full Text] [Related]
11. Variability in the prescription of cholinesterase inhibitors and memantine. Villar-Fernández I; Bjerrum L; Feja C; Rabanaque MJ Dement Geriatr Cogn Disord; 2009; 28(4):373-9. PubMed ID: 19887800 [TBL] [Abstract][Full Text] [Related]
12. [The clinical relevance of memantine use]. Sobów T Psychiatr Pol; 2004; 38(2):321-30. PubMed ID: 15307296 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI). Ferris S; Schneider L; Farmer M; Kay G; Crook T Int J Geriatr Psychiatry; 2007 May; 22(5):448-55. PubMed ID: 17117395 [TBL] [Abstract][Full Text] [Related]
14. Memantine for dementia? Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973 [TBL] [Abstract][Full Text] [Related]
15. Therapies for Alzheimer's disease. Melnikova I Nat Rev Drug Discov; 2007 May; 6(5):341-2. PubMed ID: 17539055 [No Abstract] [Full Text] [Related]
16. Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients. Vidal JS; Lacombe JM; Dartigues JF; Pasquier F; Robert P; Tzourio C; Alpérovitch A Alzheimer Dis Assoc Disord; 2008; 22(2):125-30. PubMed ID: 18525283 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of memantine. Johnson JW; Kotermanski SE Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266 [TBL] [Abstract][Full Text] [Related]
18. FDA approves memantine drug for treating AD. Am J Alzheimers Dis Other Demen; 2003; 18(6):329-30. PubMed ID: 14682078 [No Abstract] [Full Text] [Related]
19. [Efficacy of memantine in the treatment of Alzheimer's disease]. Molinuevo Guix JL; Lladó Plarrumaní A Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590 [TBL] [Abstract][Full Text] [Related]
20. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Danysz W; Parsons CG Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]